iFLYTEK Medical (02506) partners with Youplus Health and Centre Testing International Group to settle in the Hong Kong Science Park, jointly launching a new era of intelligent transformation in the longevity health industry.

On April 15th, the "Smart Health Leading the Future" Health Management Innovation Summit was successfully held, jointly organized by XUNFEIHEALTH Limited (02506), UJIA Health International Limited, and Centre Testing International Group Certification Group, with support from Hong Kong Science Park Corporation, Hong Kong Productivity Council, and Invest Hong Kong. At the event, Xunfei Medical, UJIA Health, and Centre Testing International Group officially entered into a strategic cooperation agreement, launching a collaborative project in Hong Kong Science Park. Together, they will work to transform the health management industry towards precision, intelligence, and prevention, initiating a new journey for the development of longevity and health industry. Mr. Wong Ping Sau, CEO of Hong Kong Science Park Corporation, praised the three-party cross-border cooperation in his opening speech. He stated, "Today's event witnessed the strong cross-border integration of Xunfei Medical, UJIA Health, and Centre Testing International Group, combining medical service experience, international-level testing and certification capabilities, and cutting-edge artificial intelligence technology, reflecting the crucial role of Science Park as an innovation platform. By connecting healthcare, scientific research, and technology enterprises, we are promoting health management to shift from 'treating diseases' to 'prevention-based, people-oriented' longevity solutions, while bolstering the local innovation ecosystem." Mr. Wong further introduced Hong Kong Science Park as a leading innovation hub in Asia, currently supporting over 300 life sciences and health technology companies. The Park houses a 22,000 square foot Biomedical Technology Support Centre with over 300 sets of advanced equipment, and collaborates with the Hospital Authority on a data platform to accelerate artificial intelligence applications. Looking ahead, the Science Park will deepen industry-academic-research collaboration, attract more enterprises and talent, and help Hong Kong become a global hub for health technology, leading technology expansion in the Greater Bay Area and global markets, jointly creating the future of health technology. In his speech, Mr. Tao Xiaodong, President of Xunfei Medical, expressed, "Artificial intelligence is the core force driving the transformation of the big health industry, effectively addressing industry pain points such as uneven distribution of medical resources and insufficient health service supply. Since its establishment in 2016, Xunfei Medical has focused on medical core scenarios, empowering diagnosis and treatment with artificial intelligence. With nearly a decade of deep cultivation, our business now covers all 31 provinces, autonomous regions, and municipalities in China, serving over 250,000 grassroots doctors and more than 600 hospitals, accumulating solid technological strength and clinical application foundations. The company has always considered Hong Kong as a strategic pivot for international deployment, having previously launched the Xinghuo Medical Large Model International Edition and the personal health assistant 'Xunfei Xiaoyi' Hong Kong Edition, providing Hong Kong citizens with technology support for comprehensive health management and facilitating the digital and intelligent upgrade of the local health industry." The core goal of human health development is not just to extend life expectancy, but to enhance healthy life expectancy. Currently, average life expectancy continues to increase, but healthy life expectancy lags significantly behind, highlighting the strategic value of proactive health management, early screening, and early intervention. Xunfei Medical is shifting its business focus from "treating diseases" to "preventing diseases," adhering to a preventive approach to reduce the risk of disease occurrence and development from the source. Regarding the three-party cooperation, Mr. Tao Xiaodong pointed out that the project settling in Hong Kong Science Park is a key step for complementary advantages and collaborative innovation among the parties. The three parties will deeply integrate the high-quality data of Centre Testing International Group, the professional service capabilities of UJIA Health, and the clinical knowledge and AI core technology of Xunfei Medical to build a "high-quality data + expert knowledge + intelligent service" full-chain collaborative closed loop. "We will take Hong Kong as the pilot, strictly adhere to compliance standards, uphold professional and prudent principles, and fully develop a replicable and globally scalable innovative health management service model, leading the industry towards a new era of individualization and precision." Mr. Guo Yongchun, CEO of UJIA Health International Limited, stated, "UJIA Health upholds the concept of 'prevention as the cure,' advocating that health management should be accumulated like wealth for the long term, emphasizing early intervention before the onset of diseases. The company has announced a strategic cooperation with Centre Testing International Group and Xunfei Medical to integrate functional medicine testing, creating a precise and personalized health management closed-loop ecosystem." Mr. Guo further pointed out that through settling in Science Park and combining advanced wearable devices, Alpha Care is committed to popularizing "proactive health management" to every household, optimizing life capital from the source. Its ultimate vision is to enable the public to have a vibrant and long life in old age through continuous management, achieving the goal that "health is the greatest wealth." Mr. Shen Tu Xianzhong, President of Centre Testing International Group, remarked, "Today, Huace Group, UJIA Health, and Xunfei Medical jointly launched the 'AI + functional medicine' three-party cooperation, marking a new journey for health management towards New Journey Health Technology Group. As a leading third-party testing organization in China, Huace has a market share of over 70% in the field of functional medicine testing, with a cumulative sample size exceeding 500,000 cases, providing the most reliable data foundation for this cooperation. He emphasized that the future of health management should shift from 'treating diseases' to 'preventing diseases' and 'proactive health management.' Through combining Huace's precise testing, Xunfei Medical's AI technology, and UJIA Health's personalized services, the three parties will establish a complete value chain loop from testing, AI analysis to nutritional intervention. Hong Kong Science Park is a key gateway for Huace's global outreach, leveraging its international research resources, the company will focus on developing an 'AI functional health platform' and driving commercialization, supported by government agencies, to set a new benchmark for global longevity health management and improve people's quality of life." The event featured keynote speeches and roundtable discussions, showcasing innovative approaches in longevity and health management, bringing together industry leaders from health technology, functional medicine, wearable technology, and related fields to share cutting-edge insights and best practices. The keynote speeches focused on the development of functional medicine, exploring how it can drive the transformation of health management from 'treating diseases' to 'preventing diseases,' providing new ideas for industry development. Additionally, roundtable discussions were held on the topics of 'advanced testing and proactive health management' and 'AI empowering personalized health in the new era.' Mr. Ren Yong, Deputy Director of Xunfei Medical's Hong Kong Research Institute, stated during the roundtable discussion, that artificial intelligence is driving health management from fragmented monitoring to systematic and comprehensive services. Xunfei Medical relies on multidimensional health data integration and large-scale model technology to build a precise, continuous, and intelligent health management system, making AI an important support for assisting clinical decision-making, optimizing health intervention, and connecting both medical professionals and patients. Leveraging Hong Kong's international platform, Xunfei Medical will continue to advance the adaptation of medical AI to international standards and local scenarios, empowering personalized health services with technological innovation. As an international innovation hub, Hong Kong is an important gateway for Xunfei Medical to connect to global markets. Xunfei Medical will use Hong Kong as its core base to create a digital health governance system that meets international standards and can be replicated and promoted globally, using AI technology to drive high-quality development of the global health industry. Looking to the future, Xunfei Medical will continue to leverage its leading position in the AI industry chain, collaborating with partners to deepen the research and application of medical large models, accelerating the deep integration of digital and intelligent technology with the medical industry, contributing wisdom and strength to the improvement of medical quality and resource balance in Hong Kong and globally.